1. Home
  2. BLTE vs BVN Comparison

BLTE vs BVN Comparison

Compare BLTE & BVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$129.67

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Logo Buenaventura Mining Company Inc.

BVN

Buenaventura Mining Company Inc.

N/A

Current Price

$19.51

Market Cap

6.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
BLTE
BVN
Founded
2018
1953
Country
United States
Peru
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.9B
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
BLTE
BVN
Price
$129.67
$19.51
Analyst Decision
Strong Buy
Hold
Analyst Count
9
6
Target Price
★ $233.00
$36.83
AVG Volume (30 Days)
142.0K
★ 1.0M
Earning Date
11-12-2026
10-29-2026
Dividend Yield
N/A
★ 5.35%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.16
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$21.78
Revenue Growth
N/A
N/A
52 Week Low
$115.41
$21.21
52 Week High
$200.00
$44.67

Technical Indicators

Market Signals
Indicator
BLTE
BVN
Relative Strength Index (RSI) 32.18 19.10
Support Level N/A N/A
Resistance Level $158.76 $36.50
Average True Range (ATR) 9.11 1.21
MACD -1.46 -0.61
Stochastic Oscillator 19.04 4.60

Price Performance

Historical Comparison
BLTE
BVN

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About BVN Buenaventura Mining Company Inc.

Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.

Share on Social Networks: